Вы искали: phototoxicity (Английский - Мальтийский)

phototoxicity
fototossiċità

patient alert card for phototoxicity and scc:
il-kard t’allert għal fototossiċità u scc:

reminds patients of the risk of phototoxicity and skin scc.
ifakkar lil pazjenti dwar ir-riskju ta’ fototossiċità u scc tal-ġilda.

however, when tested in vitro it was devoid of phototoxicity.
madankollu, meta ġie ttestjat in vitro, instab li ma kellu l-ebda fototossiċità.

an in vitro 3t3 test showed that afatinib may have phototoxicity potential.
test 3t3 in vitro wera li afatinib jista’ jkollu potenzjal ta’ fototossiċità.

no evidence of phototoxicity was observed with cotellic as a single agent.
ma kienet osservata l-ebda evidenza ta’ fototossiċità b’cotellic bħala sustanza waħedha.

a sequential approach to phototoxicity testing of chemicals is set out in the appendix.
approċċ sekwenzjali għall-prova fototossika tal-kimiċi huwa provdut fl-appendiċi.

reminds hcps of the risks of phototoxicity, skin scc and hepatotoxicity reported with voriconazole use.
għandu jfakkar lil hcps dwar ir-riskji ta’ fototossiċità, scc tal-ġilda u epatotossċità rapportata waqt l-użu b’voriconazole.

advises hcps on the risks of phototoxicity, skin scc and liver toxicity associated with voriconazole use.
jagħti parir lil hcps dwar ir-riskji ta’ fototossiċità, scc tal-ġilda u tossiċità tal-fwied assoċjati mal-użu ta’ voriconazole.

dasatinib had phototoxic potential in an in vitro neutral red uptake phototoxicity assay in mouse fibroblasts.
dasatinib kellu potenzjal fototossiku f’analiżi ta’ neutral red uptake phototoxicity in vitro f’fibroblasti tal-ġrieden.

scenesse is indicated for prevention of phototoxicity in adult patients with erythropoietic protoporphyria (epp).
scenesse huwa indikat għall-prevenzjoni ta’ fototossiċità f’pazjenti adulti bi protoporfirja eritropojetika (epp).

the phototoxicity potential of alitretinoin was assessed based on its chemical properties and data from a battery of in vitro tests.
il-potenzjal tal-fototossiċità ta’ alitretinoin kien evalwat u kien ibbażat fuq il-proprjetajiet kimiċi tiegħu u fuq tagħrif miksub minn serje ta’ testijiet in vitro.

in repeated dose toxicity studies in rats and dogs, the main undesirable effects of temoporfin were phototoxicity and adverse injection site reactions.
fi studji dwar it-tossiċita, fejn ingħataw dożi repetuti lill-firien u lill-klieb, l-effetti mhux mixtieqa prinċipali ta’ temoporfin kienu l-fototossiċità u reazzjonijiet avversi fis-sit ta’ l-injezzjoni.

in addition vfend has been associated with phototoxicity, including reactions such as ephelides, lentigo, actinic keratosis and pseudoporphyria.
barra minn hekk vfend kien assoċjat ma’ fototossiċità u pseudoporphyria, li tinkludi reazzjonijiet bħal nemex, lentigo u keratożi aktinika.

in the present test guideline, pif and mpe can be used for transformation of the results of the in vitro 3t3 nru phototoxicity test into a prediction of phototoxic potential.
fil-linja ta' gwida preżenti tal-prova, pif u mpe jistgħu jintużaw għat-trasformazzjoni tar-riżultati tal-prova ta' fototossiċità in vitro 3t3 nru fi tbassir ta' potenzjal fototossiku.

evaluation of the potential for phototoxicity in the embryonic murine fibroblast cell line balb/c 3t3 was inconclusive for idelalisib due to cytotoxicity in the in vitro assay.
evalwazzjoni ta’ fototossiċità potenzjali fir-razza ta’ ċelluli fibroblast murine embrijoniċi balb/c 3t3 ma kinitx konklussiva għal idelalisib minħabba ċitotossiċità fl-assaġġ in vitro.

iclusig has been evaluated in safety pharmacology, repeat-dose toxicity, genotoxicity, reproductive toxicity, phototoxicity and carcinogenicity studies.
iclusig ġie evalwat fi studji ta’ sigurtà farmakoloġika, tossiċità dovuta għal dożi ripetuti, ġenotossiċità tossiċità riproduttiva, studji ta’ fototossiċità u karċinoġeniċità.

non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, local tolerance, and phototoxicity.
tagħrif mhux kliniku ibbażat fuq studji konvenzjonali ta’ sigurtà farmakoloġika, effett tossiku minn dożi ripetuti, tolleranza lokali u fototossiċità, ma juri l-ebda periklu speċjali għall-bnedmin.

nilotinib has been evaluated in safety pharmacology, repeated dose toxicity, genotoxicity, reproductive toxicity, phototoxicity and carcinogenicity (rats and mice) studies.
nilotinib ġie evalwat fi studji ta’ sigurtà farmakoloġika, kif ukoll dwar tossiċità minn dożi ripetuti, ġenotossiċità, tossiċità fis-sistema riproduttiva, studji fototossiċi u dwar il-karċinoġenità (firien u ġrieden).

dermatologic evaluation should be performed on a systematic and regular basis, whenever vfend is continued despite the occurrence of phototoxicity-related lesions, to allow early detection and management of premalignant lesions.
evalwazzjoni dermatoloġika għandha titwettaq fuq bażi sistematika u regolari, kull meta vfend jitkompla minkejja l- okkorrenza ta’ leżjonijiet relatati mal-fototossiċità, biex tippermetti l-iżvelar bikri u l-immaniġġjar ta’ leżjonijiet premalinni.